Skip to content

Net Change in Cash at other companies

Baxter International logo
Baxter InternationalBAX
$51M+143%
PTH
Pelthos Therapeutics Inc.PTHS
$14.2M+3,818%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
-$16.17M-47.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$309.88M+321%
RFL
Rafael Holdings, Inc.RFL
-$7.28M
Opko Health logo
Opko HealthOPK
-$27.18M-769%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's net change in cash?
Cumberland Pharmaceuticals (CPIX) reported net change in cash of -$437.45K in Q1 2026.
How has Cumberland Pharmaceuticals's net change in cash changed year-over-year?
Cumberland Pharmaceuticals's net change in cash increased by 84.7% year-over-year, from -$2.86M to -$437.45K.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.